Operating
Stock-Based Comp
Medtronic Stock-Based Comp decreased by 48.4% to $94.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.1%, from $98.00M to $94.00M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 5.7% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase may signal a strategy to preserve cash or align employee interests with shareholders, but it also results in share dilution.
Detailed definition
Stock-based compensation is a non-cash expense where employees and executives are rewarded with equity or stock options...
Peer comparison
High-growth technology firms often have higher stock-based compensation as a percentage of revenue compared to mature industrial firms.
Metric ID:
stock_based_compensationHistorical Data
20 periods
| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $69.00M | $69.00M | $140.00M | $78.00M | $72.00M | $62.00M | $137.00M | $81.00M | $75.00M | $73.00M | $146.00M | $84.00M | $90.00M | $83.00M | $159.00M | $98.00M | $89.00M | $86.00M | $182.00M | $94.00M |
| QoQ Change | — | +0.0% | +102.9% | -44.3% | -7.7% | -13.9% | +121.0% | -40.9% | -7.4% | -2.7% | +100.0% | -42.5% | +7.1% | -7.8% | +91.6% | -38.4% | -9.2% | -3.4% | +111.6% | -48.4% |
| YoY Change | — | — | — | — | +4.3% | -10.1% | -2.1% | +3.8% | +4.2% | +17.7% | +6.6% | +3.7% | +20.0% | +13.7% | +8.9% | +16.7% | -1.1% | +3.6% | +14.5% | -4.1% |
Range$62.00M – $182.00M
CAGR+6.7%
Avg YoY Growth+6.3%
Median YoY Growth+4.3%
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is Medtronic's stock-based comp?
- Medtronic (MDT) reported stock-based comp of $94.00M in Q4 2025.
- How has Medtronic's stock-based comp changed year-over-year?
- Medtronic's stock-based comp decreased by 4.1% year-over-year, from $98.00M to $94.00M.
- What is the long-term trend for Medtronic's stock-based comp?
- Over 4 years (2021 to 2025), Medtronic's stock-based comp has grown at a 5.7% compound annual growth rate (CAGR), from $344.00M to $429.00M.
- What does stock-based comp mean?
- The value of company shares given to employees as part of their pay.